These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23087427)

  • 1. Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy.
    Paroni M; Moalli F; Nebuloni M; Pasqualini F; Bonfield T; Nonis A; Mantovani A; Garlanda C; Bragonzi A
    J Infect Dis; 2013 Jul; 208(1):130-8. PubMed ID: 23087427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa.
    Moalli F; Paroni M; Véliz Rodriguez T; Riva F; Polentarutti N; Bottazzi B; Valentino S; Mantero S; Nebuloni M; Mantovani A; Bragonzi A; Garlanda C
    J Immunol; 2011 May; 186(9):5425-34. PubMed ID: 21441447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients.
    Hamon Y; Jaillon S; Person C; Giniès JL; Garo E; Bottazzi B; Ghamrawi S; Urban T; Subra JF; Bouchara JP; Mantovani A; Jeannin P; Delneste Y
    Innate Immun; 2013 Dec; 19(6):611-22. PubMed ID: 23475792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients.
    Chiarini M; Sabelli C; Melotti P; Garlanda C; Savoldi G; Mazza C; Padoan R; Plebani A; Mantovani A; Notarangelo LD; Assael BM; Badolato R
    Genes Immun; 2010 Dec; 11(8):665-70. PubMed ID: 20927127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
    Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
    Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.
    Van Heeckeren AM; Scaria A; Schluchter MD; Ferkol TW; Wadsworth S; Davis PB
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L717-26. PubMed ID: 14514520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
    Yu H; Nasr SZ; Deretic V
    Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.
    Guilbault C; Martin P; Houle D; Boghdady ML; Guiot MC; Marion D; Radzioch D
    Lab Anim; 2005 Jul; 39(3):336-52. PubMed ID: 16004694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of CFTR and Mucoid Phenotype on Susceptibility and Innate Immune Responses in a Mouse Model of Pneumococcal Lung Disease.
    Dennis EA; Coats MT; Griffin SE; Hale JY; Novak L; Briles DE; Crain MJ
    PLoS One; 2015; 10(10):e0140335. PubMed ID: 26469863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal/Permeability-Increasing Protein Preeminently Mediates Clearance of
    Theprungsirikul J; Skopelja-Gardner S; Burns AS; Wierzbicki RM; Rigby WFC
    Front Immunol; 2021; 12():659523. PubMed ID: 33981306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis.
    Isopi E; Mattoscio D; Codagnone M; Mari VC; Lamolinara A; Patruno S; D'Aurora M; Cianci E; Nespoli A; Franchi S; Gatta V; Dubourdeau M; Moretti P; Di Sabatino M; Iezzi M; Romano M; Recchiuti A
    Front Immunol; 2020; 11():581. PubMed ID: 32528461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
    Yu H; Hanes M; Chrisp CE; Boucher JC; Deretic V
    Infect Immun; 1998 Jan; 66(1):280-8. PubMed ID: 9423869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.